Replimune (REPL) Current Leases (2019 - 2026)
Replimune (REPL) reported Current Leases of $1.2 million for Q1 2026, down 2.2% on a YoY basis from $1.2 million in Q1 2025, and down 4.53% sequentially from $1.2 million in Q4 2025.
Replimune (REPL) Current Leases (2019 - 2026) Analysis & Trends
Replimune (REPL) has 8 years of Current Leases data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 2.2% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 2.2% YoY), and the FY2026 full-year result was $1.2 million, down 2.2% from the prior year.
- Current Leases declined to $1.2 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.8 million in Q3 2025 to a low of $1.0 million in Q3 2022.
- A 5-year average of $1.9 million and a median of $1.2 million in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases sank 59.14% in 2022 and surged 167.27% in 2023, its largest moves.
- Tracing REPL's Current Leases over 5 years: stood at $1.0 million in 2022, then increased by 11.93% to $1.2 million in 2023, then advanced by 0.09% to $1.2 million in 2024, then climbed by 4.21% to $1.2 million in 2025, then declined by 4.53% to $1.2 million in 2026.
- Business Quant data shows REPL's Current Leases at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 2.74 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Mar 31, 2022 | 2.56 Mn |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | 967,000.00 |
| Jun 30, 2021 | 2.51 Mn |